286 related articles for article (PubMed ID: 19491251)
1. Serum levels of ghrelin, tumor necrosis factor-alpha and interleukin-6 in infants and children with congenital heart disease.
Afify MF; Mohamed GB; El-Maboud MA; Abdel-Latif EA
J Trop Pediatr; 2009 Dec; 55(6):388-92. PubMed ID: 19491251
[TBL] [Abstract][Full Text] [Related]
2. The levels of Ghrelin, TNF-alpha, and IL-6 in children with cyanotic and acyanotic congenital heart disease.
Yilmaz E; Ustundag B; Sen Y; Akarsu S; Kurt AN; Dogan Y
Mediators Inflamm; 2007; 2007():32403. PubMed ID: 18274638
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum ghrelin, tumor necrosis factor-α and interleukin-6 in congenital heart disease.
Wang D; Fang J; Wang R; Sun D; Xia K; Yin W; Zhang S; Sun L
Pediatr Int; 2016 Apr; 58(4):259-64. PubMed ID: 26256999
[TBL] [Abstract][Full Text] [Related]
4. A study of serum levels of leptin, ghrelin and tumour necrosis factor-alpha in child patients with cyanotic and acyanotic, congenital heart disease.
Shahramian I; Noori NM; Hashemi M; Sharafi E; Baghbanian A
J Pak Med Assoc; 2013 Nov; 63(11):1332-7. PubMed ID: 24392513
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of ghrelin and TNF-α in patients with cyanotic and acyanotic congenital heart disease.
Zhang S; Guo GL; Yang LL; Sun LQ
World J Pediatr; 2017 Apr; 13(2):122-128. PubMed ID: 27878778
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin levels in children with congenital heart disease.
Kandil ME; Elwan A; Hussein Y; Kandeel W; Rasheed M
J Trop Pediatr; 2009 Oct; 55(5):307-12. PubMed ID: 19261663
[TBL] [Abstract][Full Text] [Related]
7. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions.
Dinleyici EC; Kilic Z; Buyukkaragoz B; Ucar B; Alatas O; Aydogdu SD; Dogruel N
Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262
[TBL] [Abstract][Full Text] [Related]
8. Correlation between vascular endothelial growth factor and leptin in children with cyanotic congenital heart disease.
Aydin HI; Yozgat Y; Demirkaya E; Olgun A; Okutan V; Lenk MK; Ozcan O
Turk J Pediatr; 2007; 49(4):360-4. PubMed ID: 18246735
[TBL] [Abstract][Full Text] [Related]
9. Expression of ghrelin and insulin-like growth factor-1 in immature piglet model of chronic cyanotic congenital heart defects with decreased pulmonary blood flow.
Wang D; Liu YL; Lü XD; Zhu YB; Ling F; Liu AJ; Li G; Xu YL
Chin Med J (Engl); 2011 Aug; 124(15):2354-60. PubMed ID: 21933568
[TBL] [Abstract][Full Text] [Related]
10. Does normoxemic cardiopulmonary bypass prevent myocardial reoxygenation injury in cyanotic children?
Bulutcu FS; Bayindir O; Polat B; Yalcin Y; öZbek U; Cakali E
J Cardiothorac Vasc Anesth; 2002 Jun; 16(3):330-3. PubMed ID: 12073205
[TBL] [Abstract][Full Text] [Related]
11. A Novel Brain Injury Biomarker Correlates with Cyanosis in Infants with Congenital Heart Disease.
McPhillips L; Kholwadwala D; Sison CP; Gruber D; Ojamaa K
Pediatr Cardiol; 2019 Mar; 40(3):546-553. PubMed ID: 30430186
[TBL] [Abstract][Full Text] [Related]
12. Halothane metabolism in acyanotic and cyanotic patients undergoing open heart surgery.
Moore RA; McNicholas KW; Gallagher JD; Gandolfi AJ; Sipes IG; Kerns D; Clark DL
Anesth Analg; 1986 Dec; 65(12):1257-62. PubMed ID: 3777453
[TBL] [Abstract][Full Text] [Related]
13. Chronic hypoxemia leads to reduced serum IGF-I levels in cyanotic congenital heart disease.
Dündar B; Akçoral A; Saylam G; Unal N; Meşe T; Hüdaoğlu S; Büyükgebiz B; Böber E; Büyükgebiz A
J Pediatr Endocrinol Metab; 2000 Apr; 13(4):431-6. PubMed ID: 10776998
[TBL] [Abstract][Full Text] [Related]
14. The oxidative state of children with cyanotic and acyanotic congenital heart disease.
Ercan S; Cakmak A; Kösecik M; Erel O
Anadolu Kardiyol Derg; 2009 Dec; 9(6):486-90. PubMed ID: 19965321
[TBL] [Abstract][Full Text] [Related]
15. Alterations in antioxidant and oxidant status of children after on-pump surgery for cyanotic and acyanotic congenital heart diseases.
Altin FH; Yildirim HA; Tanidir IC; Yildiz O; Kahraman MZ; Ozturk E; Celebi SB; Kyaruzi M; Bakir İ
Cardiol Young; 2017 Mar; 27(2):325-332. PubMed ID: 27194079
[TBL] [Abstract][Full Text] [Related]
16. Serum and pulmonary vascular endothelial growth factor/receptors and haemodynamic measurements in cyanotic congenital heart disease with decreased pulmonary blood flow.
Tolunay I; Tunaoglu S; Akyürek N; Halid V; Olgunturk R; Kula S
Cardiol Young; 2011 Dec; 21(6):608-15. PubMed ID: 21774842
[TBL] [Abstract][Full Text] [Related]
17. NEU3 sialidase role in activating HIF-1α in response to chronic hypoxia in cyanotic congenital heart patients.
Piccoli M; Conforti E; Varrica A; Ghiroldi A; Cirillo F; Resmini G; Pluchinotta F; Tettamanti G; Giamberti A; Frigiola A; Anastasia L
Int J Cardiol; 2017 Mar; 230():6-13. PubMed ID: 28038803
[TBL] [Abstract][Full Text] [Related]
18. Risk of Respiratory Syncytial Virus Infection in Cyanotic Congenital Heart Disease in a Subtropical Area.
Chiu SN; Shao PL; Chen HC; Lin MT; Huang LM; Kao FY; Huang SK; Wang JK; Wu MH
J Pediatr; 2016 Apr; 171():25-30.e1. PubMed ID: 26822618
[TBL] [Abstract][Full Text] [Related]
19. Whole blood coagulation measured by modified thrombelastography (ROTEM) is impaired in infants with congenital heart diseases.
Osthaus WA; Boethig D; Johanning K; Rahe-Meyer N; Theilmeier G; Breymann T; Suempelmann R
Blood Coagul Fibrinolysis; 2008 Apr; 19(3):220-5. PubMed ID: 18388502
[TBL] [Abstract][Full Text] [Related]
20. Early postoperative physical therapy for improving short-term gross motor outcome in infants with cyanotic and acyanotic congenital heart disease.
Haseba S; Sakakima H; Nakao S; Ohira M; Yanagi S; Imoto Y; Yoshida A; Shimodozono M
Disabil Rehabil; 2018 Jul; 40(14):1694-1701. PubMed ID: 28385091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
